Michael Anderson, MD
Otolaryngology · Fort Atkinson, WINPI 1588685077
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,326 of the $2,202 with a category attached, or 60.2%. Stryker accounts for 82.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $1,642 and has fallen 98.8% since, to $20 in 2025.
Across 42 payments — averaging $52.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Sanofi-aventis U.S. LLC$99
- Inspire Medical Systems, Inc.$93
- Sanofi$52
- Intersect ENT, Inc.$40
- Regeneron Healthcare Solutions, Inc.$29
- plus $81 from 5 others
What the payments were for
- Travel & lodging$1,32660%
- Food & beverage$77735%
- Education$994%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 26 | $1,807 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Inspire Medical Systems, Inc. | 2 | $93 |
| Sanofi | 2 | $52 |
| Intersect ENT, Inc. | 3 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| Aerin Medical Inc. | 2 | $24 |
| Medtronic | 1 | $20 |
| Kaleo, Inc. | 1 | $14 |
| Acclarent, Inc | 1 | $12 |
| Integra Lifesciences Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CHROMOPHARE F300$1,143
- 1788$166
How this compares
$2,202 in reported general payments places this provider in the 80th percentile of 168 otolaryngology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 27 | $2,013 |
| Fluticasone Propionate | 67 | $653 |
| Doxycycline Monohydrate | 14 | $224 |
| Azelastine Hcl | 15 | $171 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fort Atkinson
- Jason BrantMadison$103K
- B WoodsonMilwaukee$45K
- Thomas Gessertla Crosse$21K
- Colleen PleinKenosha$16K
- Steven SperryGreenfield$13K
- David PoetkerMilwaukee$13K
- Michael OldenburgGreen Bay$8K
- Jamal AhmedMarshfield$8K
- Hilel SwerdlinKenosha$8K
- Michelle MarkMadison$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.